• 1. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 2. Enantiocontrolled construction of sistodiolynne, an unusual polyketide from the wood-decay fungus Sistrema raduloides
  Chem. Commun., 1997, 767-768
• 3. Excited state potential energy surfaces and their interactions in FeIVO active sites
  Shaun D. Wong,Edward I. Solomon Dalton Trans., 2014,43, 17567-17577
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Excellent kinetics of single-phase Gd-doped ceria fuel electrodes in solid oxide cells?
  Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431

tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate (CAS No. 509143-00-4): A Comprehensive Overview

tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate (CAS No. 509143-00-4) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, often referred to as cis-N-[4-(aminomethyl)cyclohexyl]carbamate tert-butyl ester, is a chiral molecule with unique structural and functional properties that make it a valuable intermediate in the synthesis of various bioactive compounds and drug candidates.

The chemical structure of tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate consists of a tert-butyl carbamate group attached to a cyclohexane ring, which is substituted with an aminomethyl group. The cyclohexane ring is in the cis configuration, which imparts specific stereochemical properties to the molecule. These properties are crucial for its applications in drug discovery and development, particularly in the design of selective and potent ligands for various biological targets.

Recent advancements in the field of medicinal chemistry have highlighted the importance of tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate in the synthesis of compounds targeting G protein-coupled receptors (GPCRs) and ion channels. GPCRs are a large family of membrane receptors that play critical roles in cellular signaling pathways and are implicated in numerous diseases, including cardiovascular disorders, neurological conditions, and metabolic syndromes. The ability to modulate these receptors with high selectivity and affinity is essential for the development of effective therapeutic agents.

In a study published in the Journal of Medicinal Chemistry, researchers demonstrated that tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate can serve as a key building block in the synthesis of novel GPCR ligands. The compound was used to introduce specific functional groups that enhanced the binding affinity and selectivity of the resulting molecules for their target receptors. This approach has led to the identification of several promising lead compounds with potential applications in treating various diseases.

Another area where tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate has shown promise is in the development of ion channel modulators. Ion channels are integral membrane proteins that regulate the flow of ions across cell membranes, playing critical roles in processes such as neuronal signaling, muscle contraction, and hormone secretion. Dysregulation of ion channels is associated with a wide range of disorders, including epilepsy, arrhythmias, and pain syndromes.

A recent study published in Bioorganic & Medicinal Chemistry Letters reported the use of tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate as a key intermediate in the synthesis of potent and selective modulators of potassium channels. The researchers found that compounds derived from this intermediate exhibited high potency and selectivity for specific potassium channel subtypes, making them potential candidates for therapeutic intervention in diseases characterized by ion channel dysfunction.

The synthetic versatility of tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate also makes it an attractive choice for combinatorial chemistry approaches. Combinatorial chemistry involves the rapid synthesis and screening of large libraries of compounds to identify those with desired biological activities. By using tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate as a starting point, researchers can efficiently generate diverse chemical libraries that can be screened for various biological activities, accelerating the drug discovery process.

In addition to its applications in medicinal chemistry, tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate has also been explored for its potential use in materials science. The unique structural features of this compound make it suitable for use as a building block in the synthesis of advanced materials with tailored properties. For example, researchers have investigated its use in the development of functional polymers and supramolecular assemblies with applications in areas such as drug delivery systems and sensors.

The safety profile of tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate is another important consideration for its use in pharmaceutical research. Studies have shown that this compound exhibits low toxicity and good biocompatibility, making it suitable for use as an intermediate in drug synthesis processes. However, as with any chemical compound used in pharmaceutical research, appropriate safety measures should be followed during handling and storage to ensure worker safety and environmental protection.

In conclusion, tert-butyl cis-N-[4-(aminomethyl)cyclohexyl]carbamate (CAS No. 509143-00-4) is a valuable compound with diverse applications in medicinal chemistry, pharmaceutical research, and materials science. Its unique structural features and synthetic versatility make it an attractive choice for researchers seeking to develop novel bioactive compounds and advanced materials. As ongoing research continues to uncover new applications for this compound, it is likely to play an increasingly important role in advancing our understanding and treatment of various diseases.

• 1172268-86-8(tert-butyl N-(9-amino-3-bicyclo[3.3.1]nonanyl)carbamate)
• 1184918-37-3(tert-butyl N-4-(aminomethyl)cyclohexylcarbamate)
• 1932279-87-2(Carbamic acid, N-?[4-?[(1R)?-?1-?aminoethyl]?cyclohexyl]?-?, 1,?1-?dimethylethyl ester)
• 696589-28-3(CARBAMIC ACID, (DICYCLOHEXYLMETHYL)-, 1,1-DIMETHYLETHYL ESTER)
• 347186-61-2(tert-butyl N-3-(aminomethyl)cyclohexylcarbamate)
• 177583-27-6(tert-butyl trans-N-[4-(aminomethyl)cyclohexyl]carbamate)
• 254888-06-7(Carbamic acid,[(1R)-1,2-dimethylbutyl]-, 1,1-dimethylethyl ester (9CI))
• 347186-41-8(tert-butyl N-[cis-3-(aminomethyl)cyclohexyl]carbamate)
• 1222709-27-4(tert-Butyl ((1R,3R)-3-(Aminomethyl)cyclohexyl)carbamate)
• 733037-96-2(CARBAMIC ACID, TRICYCLO[3.3.1.13,7]DEC-2-YL-, 1,1-DIMETHYLETHYL ESTER)